LifePoint, Inc. (LFPI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2004 | 151.73 Thousand USD | -90.64% |
| 2003 | 1.62 Million USD | 405.9% |
| 2002 | 320.27 Thousand USD | -50.08% |
| 2001 | 641.56 Thousand USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2005 Q2 | - USD | -100.0% |
| 2005 Q3 | 59.49 Thousand USD | 0.0% |
| 2005 Q1 | 48.1 Thousand USD | -68.3% |
| 2004 FY | 151.73 Thousand USD | -90.64% |
| 2004 Q2 | 404.17 Thousand USD | -76.55% |
| 2004 Q1 | 1.72 Million USD | 6.39% |
| 2004 Q3 | 116.88 Thousand USD | -71.08% |
| 2004 Q4 | 151.73 Thousand USD | 29.81% |
| 2003 Q2 | 42.24 Thousand USD | -78.42% |
| 2003 Q3 | 1.51 Million USD | 3490.37% |
| 2003 FY | 1.62 Million USD | 405.9% |
| 2003 Q1 | 195.79 Thousand USD | -38.86% |
| 2003 Q4 | 1.62 Million USD | 6.82% |
| 2002 Q4 | 320.27 Thousand USD | -28.9% |
| 2002 FY | 320.27 Thousand USD | -50.08% |
| 2002 Q3 | 450.44 Thousand USD | -14.98% |
| 2002 Q2 | 529.81 Thousand USD | -6.58% |
| 2002 Q1 | 567.11 Thousand USD | -11.6% |
| 2001 Q3 | 749.13 Thousand USD | 1120.07% |
| 2001 Q1 | 83.17 Thousand USD | 0.0% |
| 2001 Q4 | 641.56 Thousand USD | -14.36% |
| 2001 Q2 | 61.4 Thousand USD | -26.18% |
| 2001 FY | 641.56 Thousand USD | 0.0% |
| 2000 Q3 | 124.49 Thousand USD | 187.42% |
| 2000 Q4 | - USD | -100.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q2 | 43.31 Thousand USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | 99.978% |
| Ansell Limited | 706.6 Million USD | 99.979% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | 99.323% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | 75.723% |
| ConvaTec Group Plc | 1.22 Billion USD | 99.988% |
| ConvaTec Group Plc | 1.22 Billion USD | 99.988% |
| Encision Inc. | 67.33 Thousand USD | -125.339% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | 60.366% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | 96.912% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | 75.328% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | 15.686% |
| SmileDirectClub, Inc. | 849.37 Million USD | 99.982% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | 99.928% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -212.925% |
| Vasamed, Inc. | 18.95 Thousand USD | -700.707% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -721.605% |
| Yubo International Biotech Limited | 390.44 Thousand USD | 61.138% |